Seegenschmiedt M H, Sauer R, Miyamoto C, Chalal J A, Brady L W
Strahlentherapeutische Klinik, Universität Erlangen-Nürnberg, Germany.
Am J Clin Oncol. 1993 Jun;16(3):210-22. doi: 10.1097/00000421-199306000-00005.
Twenty-six patients (20 females, 6 males) with localized tumors of the pelvis, including 3 primary advanced (PRIM), 7 persistent (PERS), 10 recurrent (REC), and 6 metastatic (MET) tumors, were treated with a combination of low-dose rate (LDR) iridium 192 interstitial radiotherapy (IRT), interstitial 915 MHz microwave hyperthermia (IHT), and external beam radiotherapy (RT). Histological diagnoses were squamous cell carcinoma in 13 (50%), adenocarcinoma in 12 (46%) and soft tissue sarcoma in 1 (4%) lesion. Tumor sites were cervix in 8 (31%), colorectum in 6 (23%), vagina in 4 (15%), anus in 3 (12%), ovary in 2 (8%), and other sites in 3 (12%) lesions. IHT was administered immediately before iridium 192 was placed and after its removal for 45-60 minutes at 41-44 degrees C. On December 31, 1991 median follow-up was 25 months (mean: 23 months; range: 5-65 months). At 3 months follow-up (FU), complete remission (CR) occurred in 17 (65%), partial remission (PR) in 7 (27%), and no change or progressive disease (NC/PD), in 2 (8%) lesions. At 12 months FU, in 16 of 21 patients (76%) local control (LC) was achieved, with 1 (5%) patient exhibiting a slow tumor regression. After combined IRT-IHT locoregional relapse or tumor regrowth occurred in 8/26 (31%): 5 (19%) outside and 3 (12%), inside the previously treated volume; relapses occurred within 8-30 (mean: 18) months of follow-up. Factors influencing initial (3 months FU) and long-term tumor response (12 months FU) included tumor class, tumor volume, total radiation dose, and thermal parameters with "good quality of heating" (TQ 41 degrees C > or = 75%) and high minimum tumor temperature (Tmin(av) > or = 41 degrees C). Treatment toxicity was acceptable: whereas 8 (31%) patients experienced acute side effects, which subsided within weeks, 7 (27%) developed long-term complications. Thermal damage was associated with IHT treatments exceeding maximum average temperatures of > or = 44 degrees C and maximum peak temperatures of > or = 45 degrees C.
26例骨盆局部肿瘤患者(20例女性,6例男性),包括3例原发性晚期(PRIM)、7例持续性(PERS)、10例复发性(REC)和6例转移性(MET)肿瘤,接受了低剂量率(LDR)铱192组织间放射治疗(IRT)、915 MHz组织间微波热疗(IHT)和外照射放疗(RT)联合治疗。组织学诊断为鳞状细胞癌13例(50%)、腺癌12例(46%)、软组织肉瘤1例(4%)。肿瘤部位:宫颈8例(31%)、结直肠6例(23%)、阴道4例(15%)、肛门3例(12%)、卵巢2例(8%)、其他部位3例(12%)。IHT在放置铱192之前及取出后立即进行,在41 - 44℃下持续45 - 60分钟。1991年12月31日,中位随访时间为25个月(平均:23个月;范围:5 - 65个月)。在3个月随访(FU)时,17例(65%)完全缓解(CR),7例(27%)部分缓解(PR),2例(8%)病变无变化或疾病进展(NC/PD)。在12个月FU时,21例患者中的16例(76%)实现了局部控制(LC),1例(5%)患者肿瘤呈缓慢消退。联合IRT - IHT治疗后,8/26例(31%)出现局部区域复发或肿瘤再生长:5例(19%)在先前治疗区域外,3例(12%)在先前治疗区域内;复发发生在随访的8 - 30个月(平均:18个月)。影响初始(3个月FU)和长期肿瘤反应(12个月FU)的因素包括肿瘤类型、肿瘤体积、总辐射剂量和热参数,即“良好加热质量”(TQ 41℃≥75%)和较高的最低肿瘤温度(Tmin(av)≥41℃)。治疗毒性可接受:8例(31%)患者出现急性副作用,数周内消退,7例(27%)出现长期并发症。热损伤与IHT治疗中平均最高温度≥44℃和最高峰值温度≥45℃相关。